ArticleClinical and translational radiation oncology2026

Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer.

Anna M Dornisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.